Australia markets close in 1 hour 16 minutes

Fulgent Genetics, Inc. (FLGT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
22.91+0.16 (+0.70%)
At close: 04:00PM EDT
22.91 0.00 (0.00%)
After hours: 04:19PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 693.95M
Enterprise value 394.59M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.36
Price/book (mrq)0.61
Enterprise value/revenue 1.36
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.50
52-week change 3-17.20%
S&P500 52-week change 329.75%
52-week high 330.68
52-week low 318.91
50-day moving average 322.77
200-day moving average 323.26

Share statistics

Avg vol (3-month) 3176.57k
Avg vol (10-day) 3118.64k
Shares outstanding 530.3M
Implied shares outstanding 630.3M
Float 820.13M
% held by insiders 132.01%
% held by institutions 151.79%
Shares short (30 Aug 2024) 4732.75k
Short ratio (30 Aug 2024) 44.47
Short % of float (30 Aug 2024) 44.35%
Short % of shares outstanding (30 Aug 2024) 42.42%
Shares short (prior month 31 July 2024) 4693.51k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 June 2024

Profitability

Profit margin -56.22%
Operating margin (ttm)-26.62%

Management effectiveness

Return on assets (ttm)-3.32%
Return on equity (ttm)-14.27%

Income statement

Revenue (ttm)290.7M
Revenue per share (ttm)9.72
Quarterly revenue growth (yoy)4.70%
Gross profit (ttm)N/A
EBITDA -43.01M
Net income avi to common (ttm)-163.43M
Diluted EPS (ttm)-5.47
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)311.71M
Total cash per share (mrq)10.29
Total debt (mrq)13.38M
Total debt/equity (mrq)1.18%
Current ratio (mrq)5.27
Book value per share (mrq)37.42

Cash flow statement

Operating cash flow (ttm)36.72M
Levered free cash flow (ttm)4.46M